Elena Pugacheva

NEDD9 depletion destabilizes Aurora A kinase and heightens the efficacy of Aurora A inhibitors: implications for treatment of metastatic solid tumors.

NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis.

NEDD9 regulates actin dynamics through cortactin deacetylation in an AURKA/HDAC6-dependent manner.

NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer.

Prometastatic NEDD9 Regulates Individual Cell Migration via Caveolin-1-Dependent Trafficking of Integrins.

AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.

Combination of Eribulin and Aurora A Inhibitor MLN8237 Prevents Metastatic Colonization and Induces Cytotoxic Autophagy in Breast Cancer.

Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.

LPA signaling is regulated through the primary cilium: a novel target in glioblastoma.

Human Breast Cancer Xenograft Model Implicates Peroxisome Proliferator-activated Receptor Signaling as Driver of Cancer-induced Muscle Fatigue.

Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype.

Nuclear Aurora-A kinase-induced hypoxia signaling drives early dissemination and metastasis in breast cancer: implications for detection of metastatic tumors.